Mucosal haemangioma in the setting of treatment with trastuzumab emtansine (T-DM1).
Saved in:
| Title: | Mucosal haemangioma in the setting of treatment with trastuzumab emtansine (T-DM1). |
|---|---|
| Authors: | Belzer A; Yale School of Medicine, New Haven, CT, USA., Silber A; Department of Medical Oncology, Yale School of Medicine, New Haven, CT, USA., Mehra S; Department of Otolaryngology, Yale School of Medicine, New Haven, CT, USA., Gilani S; Department of Pathology, Yale School of Medicine, New Haven, CT, USA., Leventhal JS; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA. |
| Source: | The British journal of dermatology [Br J Dermatol] 2022 Nov; Vol. 187 (5), pp. e168. Date of Electronic Publication: 2022 May 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
